Cholestatic pruritus in patients with Alagille syndrome (ALGS)
Genetic Disorder
Cholestatic pruritus in patients with Alagille syndrome (ALGS) is treated with 1 medication in our database, including CTEXLI. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Mirum Pharmaceuticals. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Cholestatic pruritus in patients with Alagille syndrome (ALGS) treatment below.
What help exists for Cholestatic pruritus in patients with Alagille syndrome (ALGS)
1
drugs indexed
1
with copay cards
1
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Cholestatic pruritus in patients with Alagille syndrome (ALGS)
1 total🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Cholestatic pruritus in patients with Alagille syndrome (ALGS) drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |